Improving the Therapeutic Index of IL-2 Therapy through Masking & Antibody Targeting
Time: 2:45 pm
day: Conference Day One
Details:
- Discussing masking as a strategy to reduce systemic IL-2 activity and toxicity
- Investigating how PD-1 targeting can reconstitute IL-2 activity on tumor-reactive T cells
- Exploring the potential for synergistic combination to enhance the efficacy of CD3 Bispecifics and CAR-T therapy
